Literature DB >> 9631814

Use of guidelines in treating community-acquired pneumonia.

T K Marras1, C K Chan.   

Abstract

STUDY
OBJECTIVES: Guidelines for empiric treatment of community-acquired pneumonia (CAP) have been developed to assist in prescribing appropriate antimicrobials. We studied utilization of guidelines developed by the American Thoracic, Canadian Infectious Diseases, and Canadian Thoracic Societies (ATS, CIDS, and CTS, respectively), physicians' familiarity with them, reasons that prompt deviation from them, and their effects on clinical outcomes.
DESIGN: Two-part observational study, with prospective and retrospective groups.
SETTING: A 1,100-bed, two-campus, tertiary-care teaching hospital. PATIENTS AND PARTICIPANTS: Patients admitted to the general medical ward who were being treated empirically for CAP and housestaff who provided their care.
INTERVENTIONS: Medical residents reported on patients admitted to the hospital with CAP. The charts of all unreported patients admitted with CAP over the same period were reviewed. MEASUREMENTS AND
RESULTS: One hundred twenty-two patients were prospectively described and another 130 patients were identified retrospectively. There was no difference in guidelines adherence between the prospective and retrospective groups (81% compared with 80%; p=0.94). Deviation occurred most commonly in suspected aspiration. When physicians believed that they were following guidelines, this was true in 88%. When physicians believed that they were deviating, they were actually adhering in 46%. Guidelines adherence did not alter in-hospital mortality (12% compared with 14%, p=0.92) or length of hospitalization (median, 6 days for both groups).
CONCLUSIONS: ATS/CIDS/CTS guidelines for empiric treatment of CAP are widely used in our institution. Future amendments should address aspiration more explicitly. Residents' familiarity with them could be improved. Beneficial effects on outcomes remain unproven.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631814     DOI: 10.1378/chest.113.6.1689

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Treatment and outcomes of community-acquired pneumonia at Canadian hospitals.

Authors:  B G Feagan; T J Marrie; C Y Lau; S L Wheeler; C J Wong; M K Vandervoort
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

2.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

3.  Hospital Treatment Costs and Factors Affecting These Costs in Community-Acquired Pneumonia.

Authors:  Fatma Tokgöz Akyıl; Armağan Hazar; İpek Erdem; Canan Pehlivan Öneş; Murat Yalçınsoy; İlim Irmak; Umut Sabri Kasapoğlu
Journal:  Turk Thorac J       Date:  2015-07-01

4.  Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome.

Authors:  R Menéndez; A Torres; R Zalacaín; J Aspa; J J Martín Villasclaras; L Borderías; J M Benítez Moya; J Ruiz-Manzano; F Rodríguez de Castro; J Blanquer; D Pérez; C Puzo; F Sánchez Gascón; J Gallardo; C Alvarez; L Molinos
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

Review 5.  Pneumonia in hospitalized children.

Authors:  Thomas J Sandora; Marvin B Harper
Journal:  Pediatr Clin North Am       Date:  2005-08       Impact factor: 3.278

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.